FORGOTTEN HISTORY: Jhvephoto | History Defined

Genesco Issues Steep Guidance Cut, Blames Weak UK Market And Slower Traffic

Genesco Inc. (NYSE:GCO) stock tumbled Thursday after the company reported worse-than-expected third-quarter results.

Benzinga · Dec 4, 2025

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovation and strategic adaptation.

Benzinga · Nov 21, 2025

Why Shoe Carnival Is Moving Away From Budget Shoppers And Chasing Premium Buyers

Shoe Carnival, Inc. (NASDAQ:SCVL) reported third-quarter sales of $297.155 million on Thursday, beating the street view of $296.333 million. Comparable store sales declined 2.7%.

Benzinga · Nov 20, 2025

State Street Profit Rises As CEO Touts Record Management Fees

State Street Corporation (NYSE:STT) stock fell on Friday after reporting third-quarter results.

Benzinga · Oct 17, 2025

BNY Hits Record Revenue As CEO Says Growth Strategy Is Paying Off

The Bank of New York Mellon Corporation or BNY (NYSE:BK) reported third-quarter 2025 diluted EPS of $1.88 and adjusted diluted EPS of $1.91, beating the $1.77 estimate.

Benzinga · Oct 16, 2025

EMA Backs Amgen Drug For Rare Autoimmune Disorder

The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended extending the therapeutic indication of Amgen Inc.’s (NASDAQ:AMGN) Uplizna (inebilizumab) to include the treatment of adult patients with active immunoglobulin G4-related disease (IgG4-RD).

Benzinga · Sep 19, 2025

Wolverine Expands Jordan Davis Partnership With Bold Lifestyle Collection

Wolverine, a division of Wolverine World Wide, Inc. (NYSE:WWW), announced Wednesday it is strengthening its foothold in the lifestyle market through an expanded partnership with award-winning country singer Jordan Davis.

Benzinga · Sep 10, 2025

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday.

Benzinga · Sep 9, 2025

Designer Brands, Oracle And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Benzinga · Sep 9, 2025

Shoe Carnival Lifts Profit Outlook As CEO Praises Rebanner Momentum, Stock Soars

Shoe Carnival, Inc. (NASDAQ:SCVL) shares surged Thursday after the company reported its second-quarter results.

Benzinga · Sep 4, 2025